Galapagos appoints Paul Stoffels as Chief Executive Officer
Succeeds current Chief Executive Officer and co-founder Onno van de Stolpe, following planned retirement
27-Jan-2022 -
Galapagos NV announced the appointment of Dr. Paul Stoffels as Chief Executive Officer (CEO), effective April 1, 2022. Dr. Stoffels brings an impressive track record of success in innovative drug discovery and development, and a wealth of experience in biotech and pharma, across a range of roles ...
appointments
Galapagos
personnel changes